Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients
- 27 September 2021
- journal article
- review article
- Published by Springer Nature in The Nucleus
- Vol. 64 (3) , 331-342
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-05786)
This publication has 130 references indexed in Scilit:
- Applications of CYP450 Testing in the Clinical SettingMolecular Diagnosis & Therapy, 2013
- Distribution of human CYP2C8*2 allele in three different African populationsMalaria Journal, 2012
- Celecoxib pathwaysPharmacogenetics and Genomics, 2012
- Epigenetic ModificationsCirculation, 2011
- Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritisEuropean Journal of Drug Metabolism and Pharmacokinetics, 2011
- PharmacogenomicsCirculation, 2011
- Effects ofCYP2C9*1/*13on the pharmacokinetics and pharmacodynamics of meloxicamBritish Journal of Clinical Pharmacology, 2010
- Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?PLOS ONE, 2010
- Chromatin Remodelers Act Globally, Sequence Positions Nucleosomes LocallyJournal of Molecular Biology, 2009
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006